A worth reading Analysis of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) for the period of 9-Day stands at 5.89% while the stochastic %D for the same period stands at 13.25%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)’s 20-Day Bollinger Band indicates “Hold”.

About Company

Aralez Pharmaceuticals Inc. is a global specialty pharmaceutical company. They acquire, develop and commercialize products primarily in cardiovascular, pain and other specialty areas.

Previous Day Activity Analysis

On the last trading day, Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) opened the session at $1.92 and after going down -14.72% closed at $1.68. The stock lost -0.24 points in the last trade.

Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ)’s stock fluctuated in the range of $1.64 and $1.95 during the previous active session. Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) traded with the volume of 1.59 Million with average volume of 818.94 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.24 and 43.85 respectively.

Currently the Insider Ownership of the shares of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) is at 11.1% and the shares outstanding are 78.39 Million.

Important Ratio Analysis

Some important ratios to consider here for Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) are discussed below:

Dividend yield of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 1.51 and 1.15 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 1.79 and 0 correspondingly.

The Quick Ratio of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) stands at 1.3 while the Current Ratio depicts the value of 1.3.

Return on Assets ROA of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) is at -26% whereas, Return on Equity ROE and Return of Investment ROI of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) stand at -76.9% and -26% respectively.

Stock Performance Analysis

The stock performance of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) on the basis of 5 day trade show the dip of -28.21% whereas, the monthly performance of the stock shows increase of 17.48%.

The quarterly performance of the stock remained in green zone with the value of 12.75% while six month performance of the shares of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) remained bullish with the count of 3.7%.

The yearly and YTD performance of Aralez Pharmaceuticals Inc. (NASDAQ:ARLZ) remained down at -65.07% and -61.9% respectively.